ALXN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net interest income is the income earned by banks from the fund they have on their balance sheet. Alexion Pharmaceuticals Inc's net interest income for the three months ended in Jun. 2014 was $1 Mil. Its net interest income for the trailing twelve months (TTM) ended in Jun. 2014 was $2 Mil.
Alexion Pharmaceuticals Inc's quarterly net interest income increased from Dec. 2013 ($1 Mil) to Mar. 2014 ($1 Mil) but then declined from Mar. 2014 ($1 Mil) to Jun. 2014 ($1 Mil).
Alexion Pharmaceuticals Inc's annual net interest income declined from Dec. 2011 ($1 Mil) to Dec. 2012 ($-6 Mil) but then increased from Dec. 2012 ($-6 Mil) to Dec. 2013 ($-1 Mil).
Income earned by banks from the fund they have on their balance sheet. These funds can be from customers' deposit, bank's own equity or borrowed.
Alexion Pharmaceuticals Inc Net Interest Income for the trailing twelve months (TTM) ended in Jun. 2014 was -0.44 (Sep. 2013 ) + 0.746 (Dec. 2013 ) + 1.15 (Mar. 2014 ) + 0.999 (Jun. 2014 ) = $2 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Alexion Pharmaceuticals Inc Annual Data
Alexion Pharmaceuticals Inc Quarterly Data